BridgeBio Pharma BBIO Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BridgeBio Pharma's shares (basic)?
- BridgeBio Pharma (BBIO) reported shares (basic) of 194.8M in Q1 2026.
- How has BridgeBio Pharma's shares (basic) changed year-over-year?
- BridgeBio Pharma's shares (basic) increased by 2.4% year-over-year, from 190.1M to 194.8M.
- What is the long-term trend for BridgeBio Pharma's shares (basic)?
- Over 3 years (2022 to 2025), BridgeBio Pharma's shares (basic) has grown at a 9.1% compound annual growth rate (CAGR), from 588M to 764M.
- What does shares (basic) mean?
- The average number of common shares held by investors throughout the reporting period.
- How do you interpret shares (basic)?
- An increase indicates share issuance, which may dilute existing shareholders, while a decrease indicates share buybacks.
- How does shares (basic) compare across companies?
- Standard metric for normalizing financial results across different share counts.